EE03668B1 - Stabiliseeritud farmatseutilised kompositsioonid kinupristiini ja dalfopristiini baasil ning nende valmistamine - Google Patents
Stabiliseeritud farmatseutilised kompositsioonid kinupristiini ja dalfopristiini baasil ning nende valmistamineInfo
- Publication number
- EE03668B1 EE03668B1 EEP199900127A EE9900127A EE03668B1 EE 03668 B1 EE03668 B1 EE 03668B1 EE P199900127 A EEP199900127 A EE P199900127A EE 9900127 A EE9900127 A EE 9900127A EE 03668 B1 EE03668 B1 EE 03668B1
- Authority
- EE
- Estonia
- Prior art keywords
- quinupristine
- dalfopristin
- preparation
- pharmaceutical compositions
- compositions based
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9614062A FR2755857B1 (fr) | 1996-11-19 | 1996-11-19 | Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation |
| PCT/FR1997/002047 WO1998022107A1 (fr) | 1996-11-19 | 1997-11-14 | Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE9900127A EE9900127A (et) | 1999-12-15 |
| EE03668B1 true EE03668B1 (et) | 2002-04-15 |
Family
ID=9497744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP199900127A EE03668B1 (et) | 1996-11-19 | 1997-11-14 | Stabiliseeritud farmatseutilised kompositsioonid kinupristiini ja dalfopristiini baasil ning nende valmistamine |
Country Status (45)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2772272B1 (fr) * | 1997-12-16 | 2000-01-14 | Rhone Poulenc Rorer Sa | Compositions pharmaceutiques a base de dalfopristine et de quinupristine et leur preparation |
| EP1674107B8 (en) * | 1998-09-25 | 2017-01-25 | Cubist Pharmaceuticals LLC | Use of daptomycin |
| KR100613136B1 (ko) * | 1999-03-03 | 2006-08-17 | 일라이 릴리 앤드 캄파니 | 미셀-형성 계면활성제를 함유하는 에키노칸딘 제약학적조제물 |
| TWI233805B (en) * | 1999-07-01 | 2005-06-11 | Fujisawa Pharmaceutical Co | Stabilized pharmaceutical composition in lyophilized form as antifungal agent |
| US6119269A (en) * | 1999-09-23 | 2000-09-19 | Imler; Jack | Fishing vest with removable storage container system |
| US6696412B1 (en) | 2000-01-20 | 2004-02-24 | Cubist Pharmaceuticals, Inc. | High purity lipopeptides, Lipopeptide micelles and processes for preparing same |
| FR2812549B1 (fr) * | 2000-08-03 | 2003-03-21 | Aventis Pharma Sa | Associations dalfopristine/quinupristine avec le cefpirome |
| US20060014674A1 (en) | 2000-12-18 | 2006-01-19 | Dennis Keith | Methods for preparing purified lipopeptides |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2549065B1 (fr) * | 1983-07-13 | 1985-10-25 | Rhone Poulenc Sante | Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent |
| FR2576022B1 (fr) * | 1985-01-11 | 1987-09-11 | Rhone Poulenc Sante | Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent |
| FR2599036B1 (fr) * | 1986-05-22 | 1988-09-09 | Rhone Poulenc Sante | Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent |
-
1996
- 1996-11-19 FR FR9614062A patent/FR2755857B1/fr not_active Expired - Fee Related
-
1997
- 1997-11-13 PE PE1997001017A patent/PE13999A1/es not_active Application Discontinuation
- 1997-11-13 IN IN3274DE1997 patent/IN187038B/en unknown
- 1997-11-14 TR TR1999/01096T patent/TR199901096T2/xx unknown
- 1997-11-14 DK DK97945926T patent/DK0949923T3/da active
- 1997-11-14 EP EP97945926A patent/EP0949923B1/fr not_active Expired - Lifetime
- 1997-11-14 CN CNB97198901XA patent/CN1146417C/zh not_active Expired - Fee Related
- 1997-11-14 WO PCT/FR1997/002047 patent/WO1998022107A1/fr active IP Right Grant
- 1997-11-14 PT PT97945926T patent/PT949923E/pt unknown
- 1997-11-14 RS YUP-224/99A patent/RS49608B/sr unknown
- 1997-11-14 HU HU9904327A patent/HUP9904327A3/hu unknown
- 1997-11-14 NZ NZ334949A patent/NZ334949A/xx unknown
- 1997-11-14 BR BR9713087-7A patent/BR9713087A/pt not_active Application Discontinuation
- 1997-11-14 UA UA99052713A patent/UA59376C2/uk unknown
- 1997-11-14 MA MA24866A patent/MA26448A1/fr unknown
- 1997-11-14 CZ CZ0174899A patent/CZ299913B6/cs not_active IP Right Cessation
- 1997-11-14 IL IL12960797A patent/IL129607A0/xx not_active IP Right Cessation
- 1997-11-14 SK SK660-99A patent/SK284311B6/sk not_active IP Right Cessation
- 1997-11-14 ES ES97945926T patent/ES2179375T3/es not_active Expired - Lifetime
- 1997-11-14 EE EEP199900127A patent/EE03668B1/xx not_active IP Right Cessation
- 1997-11-14 UY UY24780A patent/UY24780A1/es not_active IP Right Cessation
- 1997-11-14 JP JP52326598A patent/JP4278115B2/ja not_active Expired - Lifetime
- 1997-11-14 MY MYPI97005468A patent/MY123805A/en unknown
- 1997-11-14 AT AT97945926T patent/ATE223217T1/de not_active IP Right Cessation
- 1997-11-14 PL PL97333850A patent/PL190164B1/pl not_active IP Right Cessation
- 1997-11-14 EA EA199900479A patent/EA002025B1/ru unknown
- 1997-11-14 DE DE69715247T patent/DE69715247T2/de not_active Expired - Lifetime
- 1997-11-14 KR KR10-1999-7004364A patent/KR100530836B1/ko not_active IP Right Cessation
- 1997-11-14 CA CA002271095A patent/CA2271095C/fr not_active Expired - Fee Related
- 1997-11-14 AU AU51256/98A patent/AU740291B2/en not_active Ceased
- 1997-11-14 AP APAP/P/1999/001530A patent/AP998A/en active
- 1997-11-15 JO JO19971992A patent/JO1992B1/en active
- 1997-11-17 HR HR970615A patent/HRP970615B1/xx not_active IP Right Cessation
- 1997-11-18 TN TNTNSN97184A patent/TNSN97184A1/fr unknown
- 1997-11-18 DZ DZ970199A patent/DZ2349A1/xx active
- 1997-11-19 ZA ZA9710435A patent/ZA9710435B/xx unknown
- 1997-11-19 TW TW086117271A patent/TW474816B/zh not_active IP Right Cessation
- 1997-11-19 AR ARP970105410A patent/AR008695A1/es unknown
- 1997-11-19 CO CO97067661A patent/CO4910113A1/es unknown
- 1997-11-26 SA SA97180645A patent/SA97180645B1/ar unknown
-
1999
- 1999-04-26 IL IL129607A patent/IL129607A/en unknown
- 1999-05-19 US US09/314,070 patent/US5994338A/en not_active Expired - Lifetime
- 1999-05-19 NO NO992399A patent/NO992399D0/no not_active Application Discontinuation
- 1999-05-19 OA OA9900100A patent/OA11047A/fr unknown
- 1999-05-19 BG BG103412A patent/BG63621B1/bg unknown
-
2000
- 2000-03-23 HK HK00101793A patent/HK1022832A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ITMI950529A0 (it) | Composizioni farmaceutiche e procedimento per la loro preparazione | |
| IL121236A0 (en) | Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them | |
| DK0833612T3 (da) | Ny farmaceutisk sammensætning med bedøvende virkning | |
| EP0950665A4 (en) | PHYSIOLOGICALLY ACTIVE MODIFIED PROTEINS AND DRUG COMPOSITIONS CONTAINING THEM | |
| IL119995A0 (en) | Pyrido-fused thienyl - and furanyl-oxazolidinones their preparation and pharmaceutical compositions containing them | |
| IL124994A (en) | Taxoids preparation thereof and pharmaceutical compositions containing same | |
| DK0936913T4 (da) | Oralt farmaceutisk præparat indeholdende ibandronat | |
| BR9602758A (pt) | Composição farmacêutica oral organoleticamente aceitável | |
| IL128058A0 (en) | Illudin analogs and pharmaceutical compositions containing the same | |
| EE200000226A (et) | 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon | |
| EE9900034A (et) | Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine | |
| HUP0101701A3 (en) | Substituted betha-alanines and pharmaceutical compositions comprising them | |
| IL125998A0 (en) | Taxoids preparation thereof and pharmaceutical compositions containing them | |
| EE9900127A (et) | Stabiliseeritud farmatseutilised kompositsioonid kinupristiini ja dalfopristiini baasil ning nende valmistamine | |
| HUP0000460A3 (en) | Imidazopyridazines and pharmaceutical compositions thereof | |
| ZA9811470B (en) | Pharmaceutical compositions based on dalfopristine and on quinupristine and their preparation | |
| ID18698A (id) | Komposisi farmasi | |
| ITMI951417A0 (it) | Composizioni farmaceutiche e procedimento per la loro preparazione | |
| ZA974125B (en) | Oral pharmaceutical compositions | |
| DE29723220U1 (de) | Mittel zur peroralen Verabreichung | |
| SI0949923T1 (en) | Stabilised pharmaceutical compositions, based on quinupristine and dalfopristine, and their preparation | |
| GB9412778D0 (en) | Pharmaceutical compositions and preparation thereof | |
| GB9625171D0 (en) | Pharmaceutical compositions and devices for their administration | |
| SI1011646T1 (en) | Pharmaceutical compositions and devices for their administration | |
| GB9620592D0 (en) | Pharmaceutical compositions and their use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB4A | Valid patent at the end of a year |
Effective date: 20021231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20031231 |
|
| GB1A | Change in the ownership or in the address of the owner | ||
| KB4A | Valid patent at the end of a year |
Effective date: 20041231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20051231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20061231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20071231 |
|
| MM4A | Lapsed by not paying the annual fees |
Effective date: 20071114 |